Semaglutide is a drug that belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists
Ethics approval This review article exclusively utilizes publicly accessible data and does not involve human or animal subjects, interventions, or direct interactions with participants
2010;17(12):1553-6 Pederson ES, Krishnan R, Harding JW, Wright JW
Neurodegeneration and AD models: exenatide Considering the successful neuroprotection of GLP-1RAs in in vivo diabetic models, researchers have directly tested GLP-1RAs in in vivo models of neurodegenerative diseases, including toxin-induced and transgenic models
Balanced Perspective: Conditional Game Changer The evidence suggests that GLP-1 agonists represent a conditional game changertransformative for appropriate patients with adequate access and support, but with significant limitations that prevent universal application
Longland, T